E
Entera Bio Ltd. (ENTX)
NCM – Real Time Price. Currency in USD
1.13
+0.10 (9.71%)
At close: Mar 27, 2026, 4:00 PM EDT
1.18
+0.05 (4.42%)
After-hours: Mar 27, 2026, 7:10 PM EDT
Get all premium features to the best stock analysis tool
NCM – Real Time Price. Currency in USD
1.13
+0.10 (9.71%)
At close: Mar 27, 2026, 4:00 PM EDT
1.18
+0.05 (4.42%)
After-hours: Mar 27, 2026, 7:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.83 | 6.05 | 10 | |
| Quick ratio | 10.83 | 5.63 | 10 | |
| Debt to Equity | 0.01 | 0.30 | 9.0 | |
| Debt to Assets | 0.01 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 571K | 134K | N/A | 181K | 124K |
| Gross Profit | 198K | -31K | -56K | 9K | -15K |
| Operating Income | -12M | -13M | -9M | -10M | -11M |
| Net Income | -12M | -13M | -9M | -10M | -11M |
| EBITDA | -12M | -13M | -9M | -10M | -11M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -100 | -50 | 1.0 |
| Next quarter | N/A | -83.33 | 1.0 |
| Current year | -76.8 | -12 | 1.0 |
| Next year | 129852.38 | -142.86 | 5.5 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -20.47 | -16.66 | -66.68 | 3.3 |
| Y/Y | -99.99 | -5.92 | 12.5 | -29.12 | 2.5 |
| 3y average | 274.16 | 5.81 | 18.24 | 3.45 | 7.0 |
| 5y average | 186.72 | 0.98 | -33.77 | 1.27 | 4.0 |
| Weighted average score | 4.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $16.6M significantly exceed its total debt $211.0K, ensuring strong financial flexibility
Total current assets $17.0M exceed Total current liabilities $1.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.8M limits the company's ability to reinvest or pay down debt